Biogen Inc (BIIB)

BIIB (NASDAQ:Drugs) EQUITY
$287.04
pos +0.00
+0.00%
Today's Range: 0.00 - 0.00 | BIIB Avg Daily Volume: 1,903,400
Last Update: 07/26/16 - 4:00 PM EDT
Volume: 0
YTD Performance: -6.30%
Open: $0.00
Previous Close: $287.04
52 Week Range: $223.02 - $338.51
Oustanding Shares: 219,120,762
Market Cap: 62,964,350,961
6-Month Chart
TheStreet Ratings Grade for BIIB
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 10 9 9 10
Moderate Buy 2 2 2 2
Hold 5 5 6 8
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.68 1.72 1.79 1.88
Latest Dividend: 0.00
Latest Dividend Yield: 0.00%
Dividend Ex-Date: 12/31/69
Price Earnings Ratio: 20.29
Price Earnings Comparisons:
BIIB Sector Avg. S&P 500
20.29 17.60 12.90
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
1.90% -4.33% 28.58%
GROWTH 12 Mo 3 Yr CAGR
Revenue 10.80 0.90 0.25
Net Income 22.20 1.60 0.37
EPS 24.00 1.60 0.38
Earnings for BIIB:
EBITDA 4.28B
Revenue 9.42B
Average Earnings Estimates
Qtr (09/16) Qtr (12/16) FY (12/16) FY (12/17)
Average Estimate $4.95 $4.93 $20.11 $20.78
Number of Analysts 20 20 13 20
High Estimate $5.24 $5.29 $20.49 $22.70
Low Estimate $4.57 $4.50 $19.84 $18.93
Prior Year $4.48 $4.50 $17.01 $20.11
Growth Rate (Year over Year) 10.41% 9.63% 18.23% 3.31%
Chart Benchmark
Average Frequency Timeframe
Indicator Chart Scale  
Symbol Comparison Bollinger Bands

Where Is the Insider Buying? Real Money Pro($)

The market is off its worst levels of the day. Big biotech and biopharma are providing strength today, with Biogen (BIIB) , Gilead Sciences (GILD) and Mylan (MYL) all sporting solid gains in a down market. Energy has made a bit of a comeback, but still is down nearly 2% on the day.

I'm Bullish on Biotechs Real Money Pro($)

The market continues to trade lower as we late morning, with Tobira Therapeutics (TBRA) serving as the "disaster du jour" in the small-cap biotech space.
Bullish
Jul 22, 2016 | 7:26 AM EDT
Shares of BIIB now seen reaching $360, according to Leerink Partners. Estimates also increased, as price and volume growth is driving m...
General Motors crushed Wall Street earnings estimates before the opening bell.
The charitable trust sold out of its position in Biogen while also trimming its holdings in Target.
The organic food producer was downgraded to 'Hold' by Jefferies.
Any turn in the fundamentals or sentiment easily can send these shares trading much higher from here.

Biogen: Quality at a Discount Real Money Pro($)

Biotechs now offer some great valuations, and BIIB is prime example.
Action Alerts PLUS holdings Apple, Biogen and Costco make moves in the market with Brexit concerns, drug prospects and overall vulnerability. 
But above all, know your time frame.

Columnist Conversations

The stock and bond markets have been as close to being "closed" as they can get while the lights are still on....
Since its recovery-rally high at 101 last Thursday, Apple Inc. (AAPL) has given back about 40% of the entire u...
View Chart »  View in New Window » I like GDX on the buy side as long as we can hold ab...
First off, GILD was an unmitigated disaster, we cut this and ran. this is ugly here, we'll take this off...

REAL MONEY'S BEST IDEAS

News Breaks

Powered by

BROKERAGE PARTNERS

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.


TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.